Amrutanjan Health Care · NSE: AMRUTANJAN · BSE: 590006
Q1 FY21 results · Apr–Jun 2020
Amrutanjan Health Care reported revenue from operations of ₹46.62 crore (up 4.5% from Q1 FY20) and net profit of ₹6.43 crore for Q1 FY21 (Apr–Jun 2020), on a standalone basis.
| Item | Q1 FY21 | Q1 FY20 | YoY | Q4 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 46.62 | 44.60 | +4.5% | 59.29 | −21.4% |
| Other income | 2.05 | 1.55 | +31.6% | 2.64 | −22.5% |
| Total income | 48.66 | 46.15 | +5.4% | 61.93 | −21.4% |
| Profit before tax | 8.66 | (0.91) | Turned profit | 10.64 | −18.6% |
| Net profit for the period | 6.43 | (0.70) | Turned profit | 7.89 | −18.6% |
| EPS, basic (₹) | 2.20 | (0.24) | Turned profit | 2.70 | −18.5% |
| Net margin (%) | 13.8 | -1.6 | 13.3 |
Standalone
- Filed with BSE
- 13 Aug 2020, 15:41 IST
- Board meeting
- 13 Aug 2020
- Period
- 01 Apr 2020 to 30 Jun 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE